Suchergebnisse - "Wei, Panjian"

PubPharm (16)

1

Establishment of novel anti-TIM-3 antibodies interfering with its binding to ligands

enthalten in: Heliyon | 2024

von Yan, Z. | Ma, T. | Wang, X. | +4

2

T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Yi, L. | Xu, Z. | Ma, T. | +7

3

T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC

enthalten in: Cancer immunology immunotherapy | 2024

von Yi, L. | Xu, Z. | Ma, T. | +7

4

Costimulatory capacity of CD137 mAbs on T cells depends on elaborate CRD structures but not on blocking ligand-receptor binding

enthalten in: European journal of immunology | 2023

von Jin, X. | Yi, L. | Wang, X. | +4

5

Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation

enthalten in: Life sciences | 2023

von Fu, Y. | Zhang, C. | Xie, H. | +12

6

Immunoassay with Novel Paired Antibodies for Detection of Lipoarabinomannan in the Pleural Fluid and Plasma of Patients with Tuberculous Pleurisy

enthalten in: Microorganisms | 2023

von Yan, Z. | Wang, J. | Pang, Y. | +7

7

Anti-human CD137 antibody and application thereof

enthalten in: Europäisches Patentamt | 2023

von WANG XIAOJUE | LI SHUPING | ZHANG HONGTAO | +5

8

Anti-human CD137 antibody and application thereof

enthalten in: Europäisches Patentamt | 2023

von WANG XIAOJUE | LI SHUPING | ZHANG HONGTAO | +5

9

Association between response to anti-PD-1 treatment and blood soluble PD-L1 and IL-8 changes in patients with NSCLC

enthalten in: Discover. Oncology | 2023

von Yi, L. | Wang, X. | Fu, S. | +6

10

Enhanced Serum IgG Detection Potential Using 38KD-MPT32-MPT64, CFP10-Mtb81-EspC Fusion Protein and Lipoarabinomannan (LAM) for Human Tuberculosis

enthalten in: Pathogens (Basel, Switzerland) | 2022

von Yan, Z. | Wang, X. | Yi, L. | +6